Skip to main content
. Author manuscript; available in PMC: 2020 Oct 1.
Published in final edited form as: Obstet Gynecol. 2019 Oct;134(4):840–849. doi: 10.1097/AOG.0000000000003496

Table 2:

Prevalence of CIN2+ (per 100 women living with HIV) who tested positive for high-risk HPV and underwent colposcopy

HPV type Number undergoing colposcopy
(n)
Number with CIN2+
(n)
Prevalence of CIN2+ (%)
[95% CI]
Any high-risk HPV type 82 29 35% [25 – 47]
HPV 16* 13 4 31% [9 – 61]
HPV 18/45* 19 4 21% [6 – 46]
Other high-risk HPV type* 61 26 43% [30 – 56]
>1 high-risk HPV type 11 5 45% [17 – 77]
*

Infection with these sub-types is not mutually exclusive

CIN2+: cervical intraepithelial neoplasia grade 2 or higher